Magnitude of the disease burden from neurocysticercosis in a developing country

Clinical Infectious Diseases

Volumn 29, Issue 5, 1999, Pages 1203-1209

  Bern, Caryn ^a   Garcia, Hector H ^c   Evans, Carlton ^e   Gonzalez, Armando E ^d   Verastegui, Manuela ^c   Tsang, Victor C W ^a   Gilman, Robert H ^b,c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^d UNIVERSIDAD NACIONAL MAYOR DE SAN MARCOS   (Peru)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BODY BURDEN; DEVELOPING COUNTRY; ENDEMIC DISEASE; HUMAN; MAJOR CLINICAL STUDY; NEUROCYSTICERCOSIS; PERU; POPULATION RESEARCH; PRIORITY JOURNAL; SEROPREVALENCE;

ANIMALS; DEVELOPING COUNTRIES; HUMANS; NEUROCYSTICERCOSIS; PERU; SEROEPIDEMIOLOGIC STUDIES; SWINE;

EID: 0033496291     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/313470     Document Type: Article

References (48)

1. 1. Craig PS, Rogan MT, Allan JC. Detection, screening and community epidemiology of taeniid cestode zoonoses: cystic echinococcosis, alveolar echinococcosis and neurocysticercosis. Adv Parasitol 1996; 38:169-250.
2. 2. Placencia M, Shorvon SD, Paredes V, et al. Epileptic seizures in an Andean region of Ecuador: incidence and prevalence and regional variation. Brain 1992; 115:771-82.
3. 3. Senanayake N, Roman GC. Epidemiology of epilepsy in developing countries. Bull World Health Organ 1993; 71:247-58.
4. 4. Del Brutto OH, Wadia NH, Dumas M, Cruz M, Tsang VC, Schantz PM. Proposal of diagnostic criteria for human cysticercosis and neurocysticercosis. J Neurol Sci 1996; 142:1-6.
5. 5. Carpio A, Escobar A, Hauser WA. Cysticercosis and epilepsy: a critical review. Epilepsia 1998; 39:1025-40.
6. 6. Monteiro L, Coelho T, Stocker A. Neurocysticercosis - a review of 231 cases. Infection 1992; 20:61-5.
7. 7. King CH. Cestodes (tapeworms). In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas and Bennett's principles and practice of infectious disease. 4th ed. New York: Churchill Livingstone, 1995:2544-53.
8. 8. Del Brutto OH. Neurocysticercosis. Curr Opin Neurol 1997; 10:268-72.
9. 9. Dixon HBF, Lipscomb FM. Cysticercosis: an analysis and follow-up of 450 cases. London: Privy Council, Medical Research Council, 1961:1-58.
10. 10. Padma MV, Behari M, Misra NK, Ahuja GK. Albendazole in neurocysticercosis. Natl Med J India 1995; 8:255-8.
11. 11. Baranwal AK, Singhi PD, Khandelwal N, Singhi SC. Albendazole therapy in children with focal seizures and single small enhancing computerized tomographic lesions: a randomized, placebo-controlled, double blind trial. Pediatr Infect Dis J 1998; 17:696-700.
12. 12. Del Brutto OH, Santibanez R, Noboa CA, Aguirre R, Diaz E, Alarcon TA. Epilepsy due to neurocysticercosis: analysis of 203 patients. Neurology 1992; 42:389-92.
13. 13. Garcia HH, Martinez M, Gilman R, et al. Diagnosis of cysticercosis in endemic regions. Lancet 1991; 338:549-51.
14. 14. Garcia HIT, Herrera G, Gilman RH, et al. Discrepancies between cerebral computed tomography and western blot in the diagnosis of neurocysticercosis. Am J Trop Med Hyg 1994; 50:152-7.
15. 15. Cruz I. Epidemiology of neurocysticercosis in Ecuador. In: Garcia HH, Martinez SM, eds. Taenia solium taeniasis/cysticercosis. 2nd ed. Lima: Editorial Universe S.A., 1999:289-96.
16. 16. Garcia-Noval J, Silva FdM, Moreno E, et al. Epidemiologia de la taeniasis/ cisticercosis en dos comunidades de Guatemala. Guatemala City, Guatemala: Universidad de San Carlos de Guatemala, 1996:1-24.
17. 17. Tsang VC, Brand JA, Boyer AE. An enzyme-linked immunoelectrotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis (Taenia solium). J Infect Dis 1989; 159:50-9.
18. 18. Wilson M, Bryan RT, Fried JA, et al. Clinical evaluation of the cysticercosis enzyme-linked immunoelectrotransfer blot in patients with neurocysticercosis. J Infect Dis 1991; 164:1007-9.
19. 19. Diaz JF, Verastegui M, Gilman RH, et al. Immunodiagnosis of human cysticercosis (Taenia solium): a field comparison of an antibody enzyme-linked immunosorbent assay (ELISA), an antigen-ELISA, and an enzyme-linked immunoelectrotransfer blot (EITB) assay in Peru. Am J Trop Med Hyg 1992; 46:610-5.
20. 20. Moro PL, Guevara A, Verastegui M, et al. Distribution of hydatidosis and cysticerecosis in different Peruvian populations as demonstrated by an enzyme-linked immunoclectrotransfer blot (EITB) assay. The Cysticercosis Working Group in Peru (CWG). Am J Trop Med Hyg 1994; 51: 851-5.
21. 21. Diaz F, Garcia HH, Gilman RH, et al. Epidemiology of taeniasis and cysticercosis in a Peruvian village. Am J Epidemiol 1992; 135:875-82.
22. 22. Garcia HH, Gillman R, Martinez M, et al. Cysticercosis as a major cause of epilepsy m Peru. Lancet 1993; 341:197-200.
23. 23. Garcia HH, Gillman RH, Tovar MA, et al. Factors associated with Taenia solium cysticercosis: analysis of nine hundred forty-six Peruvian neurologic patients. Am J Trop Med Hyg 1995; 52:145-8.
24. 24. Garcia HH, Gilman RH, Gonzalez AE, Tsang VCW, Verastegui M. Epidemiology of Taenia solium infection in Peru. In: Garcia HH, Martinez SM, eds. Taenia solium Teniasis/cysticercosis. 2nd ed. Lima: Editorial Universo S.A., 1999:297-305.
25. 25. Garcia HH, Gilman RH, Gonzalez AE., et al. Human and porcine Taenía solium infection in a vilage in the hihglands of Cuzco, Peru. Acta Tropica 1999; 73:31-6.
26. 26. Garcia HH, Gilman RH, Tsang VC, Gonzalez AE. Clinical significance of neurocysticercosis in endemic villages. Trans R Soc Trop Med Hyg 1997; 91:176-8.
27. 27. Instituto Nacional de Estadistica e Informatica. Datos del Censo Nacional de 1993. Lima: Gobierno de Peru, 1997.
28. 28. Schautz PM, Sarti E, Plancarte A, et al. Community-based epidemiological investigations of cysticercosis due to Taenia solium: comparison of serological screening tests and clinical findings in two populations in Mexico. Clin Infect Dis 1994; 18:879-85.
29. 29. Monteiro L, Nunes B, Mendonca D, Lopes J. Spectrum of epilepsy in neurocysticercosis: a long-term follow-up of 143 patients. Acta Neurol Scand 1995; 92:33-40.
30. 30. Zuloaga L, Soto C, Jaramillo D, Mora O, Betancur C, Londono R. Prevalence of epilepsy in Medellin, Colombia, 1983. Bol Oficina Sanit Panam 1988; 104:331-44.
31. 31. Garcia HH, Araoz R, Gilman RH, et al. Increased prevalence of cysticercosis and tacniasis among professional fried pork vendors and the general population of a village in the Peruvian highlands. Am J Trop Mud Hyg 1998; 59:902-5
32. 32. Gonzalez AE, Cama V, Gilman RH, et al. Prevalence and comparison of serologic assays, necropsy, and tongue examination for the diagnosis of porcine cysticercosis in Peru. Am J Trop Med Hyg 1990:43:194-9.
33. 33. Martinez MA, Martinez SM, Padilla C, et al. Clinical aspects and unsolved questions in cysticercosis. In: Garcia HH, Martinez SM, eds. In: Garcia HH, Martinez SM, eds. Taenia solium taeniasis/cysticercosis. 2nd ed. Lima: Editorial Universe S.A., 1999:149-62.
34. 34. Sarti F, Schantz PM, Plancarte A, et al. Prevalence and risk factors forTaenia solium taeniasis and cysticercosis in humans and pigs in a village in Morelos, Mexico. Am J Trop Med Hyg 1992; 46:677-85.
35. 35. Garcia-Noval J, Allan JC, Fletes C, et al. Epidemiology of Taenia solium taeniasís and cysticercosis in two rural Guatemalan communities. Am J Trop Med Hyg 1996; 55:282-9.
36. 36. Tsang VCW, Garcia HH. Immunoblot diagnostic test (EITB) for Taenia soliun cysticercosis and its contribution to the definition of this under-recognized but serious public health problem. In: Garcia HH, Martinez SM, eds. Taenia soliun taeniasis/cysticercosis. 2nd ed. Lima: Editorial Universe S.A., 1999:245-54.
37. 37. Allan JC, Velasquez-Tohom M, Flutes C, et al. Mass chemotherapy for intestinal Taenia solium infection: effect on prevalence in humans and pigs. Trans R Soc Trop Med Hyg 1997; 91:595-8.
38. 38. Rodriguez-Canul R, Allan JC, Dominguez JL, et al. Application of an immunoassay to determine risk factors associated with porcine eysticercosis in rural areas of Yucatan, Mexico. Vet Parasitol 1998; 79:165-80.
39. 39. Sakai H, Sone M, Castro DM, et al. Seroprevalence of Taenia solium cyslicercosis in pigs in a rural community of Honduras. Vet Parasitol 1998;78: 233-8.
40. 40. Palacio G, Jimenez I, Garcia HH, et al. Neurocysticercosis in persons with epilepsy in Medellin, Colombia, Epilepsia 1998; 39:1334-9.
41. 41. Newell E, Vyungimana F, Geerts S, Van Kerckhoven I, Tsang VC, Engels D. Prevalence of cysticercosis in epileptics and members of their families in Burundi. Trans R Soc Trop Med Hyg 1997; 91:389-91.
42. 42. Placencia M, Farmer PJ, Jumbo L, Sander JW, Shorvon SD. Levels of stigmatization of patients with previously untreated epilepsy in northern Ecuador. Neuroepidemiology 1995; 14:147-54.
43. 43. Bending JJ, Catford JC. Epidemic of burns in New Guinea due to cerebral cysticereosis [letter]. Lancet 1983; 1:922.
44. 44. Cysticercosis Working Group in Peru, The marketing of cysticercotic pigs in the Sierra of Peru. Bull World Health Organ 1993; 71:223-8.
45. 45. Moore AC, Lutwick LI, Schantz PM, et al. Seroprevalence of cysticercosis in an Orthodox Jewish community. Am J Trop Med Hyg 1995; 53:439-42.
46. 46. Schantz PM, Moore AC, Munoz JL, et al. Neurocysticercosis in an Orthodox Jewish community in New York City. N Engl J Med 1992; 327:692-5.
47. 47. Sarti E, Schantz PM, Plancarte A, et al. Epidemiological investigation of Taenia solium taeniasis and cysticercosis in a rural village of Michoacan state, Mexico. Trans R Soc Trop Med Hyg 1994; 88:49-52.
48. 48. Schantz PM, Cruz M, Sarti E, Pawlowski Z. Potential eradicability of tacniasis and cysticercosis. Bull Pan Am Health Organ 1993; 27:397-403.